2003 - Fellow of the American Psychological Association (APA)
Mark W. Bondi focuses on Cognition, Neuropsychology, Dementia, Neuroscience and Alzheimer's disease. The concepts of his Cognition study are interwoven with issues in Developmental psychology, Cognitive psychology and Cognitive decline. His Neuropsychology study combines topics in areas such as Apolipoprotein E, Functional neuroimaging and Clinical psychology.
His work carried out in the field of Dementia brings together such families of science as Psychiatry and Neuroimaging. His Neuroscience research incorporates themes from Artificial intelligence and Pattern recognition. His Alzheimer's disease research is multidisciplinary, relying on both White matter, Internal capsule, Neuropsychological assessment, Semantic memory and Receiver operating characteristic.
Mark W. Bondi mostly deals with Cognition, Neuropsychology, Dementia, Internal medicine and Disease. His Cognition study is associated with Neuroscience. Diffusion MRI is closely connected to Traumatic brain injury in his research, which is encompassed under the umbrella topic of Neuropsychology.
His Dementia research includes themes of Alzheimer's disease and Gerontology. His Internal medicine research is multidisciplinary, incorporating elements of Pathology, Oncology and Cardiology. As part of one scientific family, Mark W. Bondi deals mainly with the area of Audiology, narrowing it down to issues related to the Developmental psychology, and often Verbal learning.
Mark W. Bondi mainly focuses on Cognition, Dementia, Internal medicine, Neuropsychology and Disease. The various areas that Mark W. Bondi examines in his Cognition study include Apolipoprotein E, Neuroimaging, Physical medicine and rehabilitation and Traumatic brain injury. His Apolipoprotein E research is multidisciplinary, incorporating elements of Cerebrospinal fluid, Neuroscience and Alzheimer's disease.
Mark W. Bondi interconnects Neuropsychological assessment, Activities of daily living, Dosing, Stage and Survival analysis in the investigation of issues within Dementia. His Internal medicine research is multidisciplinary, incorporating perspectives in Oncology and Cardiology. His studies in Neuropsychology integrate themes in fields like Cognitive impairment and Clinical psychology.
Cognition, Neuroimaging, Apolipoprotein E, Neuropsychology and Dementia are his primary areas of study. Mark W. Bondi has included themes like Clinical psychology and Traumatic brain injury in his Cognition study. His studies deal with areas such as Biomarker, Alzheimer's Disease Neuroimaging Initiative, Cognitive impairment and Sex specific as well as Neuroimaging.
His Apolipoprotein E study combines topics in areas such as Neuroscience and Cognitive decline. Many of his studies on Neuropsychology involve topics that are commonly interrelated, such as Cardiology. His research integrates issues of Alzheimer's disease and Amyloid beta in his study of Dementia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comparisons of Verbal Fluency Tasks in the Detection of Dementia of the Alzheimer Type
Andreas U. Monsch;Mark W. Bondi;Nelson Butters;David P. Salmon.
JAMA Neurology (1992)
Quantification of five neuropsychological approaches to defining mild cognitive impairment.
Amy J. Jak;Amy J. Jak;Mark W. Bondi;Mark W. Bondi;Lisa Delano-Wood;Christina Wierenga;Christina Wierenga.
American Journal of Geriatric Psychiatry (2009)
Neuropsychological Assessment of Dementia
David P. Salmon;Mark W. Bondi.
Annual Review of Psychology (2009)
fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease
Mark W. Bondi;Wes S. Houston;Lisa T. Eyler;Gregory G. Brown.
Neurology (2005)
A comparison of category and letter fluency in Alzheimer's disease and Huntington's disease.
Andreas U. Monsch;Mark W. Bondi;Nelson Butters;Jane S. Paulsen.
Neuropsychology (journal) (1994)
Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis.
Nikki H. Stricker;B. C. Schweinsburg;Lisa Delano-Wood;Lisa Delano-Wood;Christina E. Wierenga;Christina E. Wierenga.
NeuroImage (2009)
Implicit and explicit memory in Alzheimer's disease and Parkinson's disease.
Mark W. Bondi;Alfred W. Kaszniak.
Journal of Clinical and Experimental Neuropsychology (1991)
Episodic memory changes are associated with the APOE- epsilon 4 allele in nondemented older adults
Mark W. Bondi;D. P. Salmon;A. U. Monsch;D. Galasko.
Neurology (1995)
Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.
Elizabeth W. Twamley;Susan A. Legendre Ropacki;Mark W. Bondi.
Journal of The International Neuropsychological Society (2006)
Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates
Mark W. Bondi;Emily C. Edmonds;Amy J. Jak;Lindsay R. Clark.
Journal of Alzheimer's Disease (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, San Diego
University of California, San Diego
University of California, San Diego
University of California, San Diego
University of California, San Diego
University of California, San Diego
Rowan University
San Diego State University
Boston University
University of Houston
The Ohio State University
Princeton University
University College London
East Tennessee State University
Griffith University
Stanford University
Jilin University
University of Chicago
Technical University of Munich
City University of New York
Norwegian Institute for Nature Research
Hanyang University
Planetary Science Institute
Collège de France
Heidelberg University
King's College London